Abstract: Methods of using a system for real-time monitoring of blood glucose levels and other analyte levels to reduce the risk of surgical complications. The system includes an apparatus for generating radio frequency scanning data which includes a transmitter for transmitting radio waves below the skin surface of a person and a two-dimensional array of receive antennas for receiving the radio waves, including a portion of the transmitted radio waves that interact with a blood vessel of the person. The wave signal is compared to known standard waveforms, and similar waveforms are input into a machine learning algorithm to determine one or more health parameters of the person. The apparatus is used to collect glucose waveform data. A second apparatus is used to collect waveform data on another analyte. The glucose waveform is analyzed to determine the patient's blood glucose level. The system reports risks associated with the patient's glucose level.

Abstract: A method of improved surgical care with real-time devices in which a real-time glucose monitoring device and real-time non-glucose devices measure a patient's physiological parameters during surgery. The physiological parameters are analyzed, and the monitoring device reports risks in surgery, including warnings, recommendations, delayed healing, increased wound infection, kidney issues, heart problems, lung issues, neurological complications, or stroke.

Abstract: Systems and methods for improved surgical care of a patient in which real-time radio frequency glucose readings and real-time radio frequency non-glucose analyte readings are obtained during the surgical care of the patient, displayed to the caregiver in real-time, and used to inform the caregiver in real-time.

Abstract: The present invention provides a sensor unit in which a sensor inserted into a user's skin along with a needle can be kept being stably inserted into the skin without being affected by the movement of the needle in the process of the needle being separated from the user's skin. The sensor unit according to the present invention, which is attached to the user's skin to measure the user's biometric information, comprises: a sensor that includes a sensor body and an insertion part connected to the sensor body so as to be placed on a different plane from the sensor body and capable of being inserted into the user's skin; a housing base that includes a housing base hole through which the insertion part passes, and supports the sensor body; a housing cap that is coupled to the housing base and covers the sensor body; and a retention protrusion that protrudes from the housing cap to contact the sensor in order to prevent the insertion part from moving backward toward the housing cap.

Abstract: An analyte detection device with multilayer adhesive tape includes: an analyte detection module fixed on user's skin surface through an adhesive module, the adhesive module equipped with at least N (N?2) layers of the adhesive tape. The first side of the first layer of the adhesive tape is fixedly connected with the analyte detection module, and the rest of the adhesive tape is stacked on the first side of the first layer of the adhesive tape. The working time of the adhesive module can be extended and the user experience can be improved through relay use of the inner and outer adhesive tape one by one, and the outer adhesive tape delays the edge warping of the inner adhesive tape.

Abstract: A highly accurate and safe analyte sensor that detects an analyte by transmitting and receiving sensing signals in a radio or microwave frequency range of the electromagnetic spectrum is provided. The analyte sensor has at least two antennas at least one of which operates as a transmit antenna to transmit one or more of the sensing signals and at least one of which operates as a receive antenna, and the analyte sensor meets or exceeds performance parameters for integrated continuous glucose monitoring systems as set forth in 21 C.F.R. 862.1355 (Feb. 18, 2022) and is configured to emit radiofrequency radiation less than radiofrequency radiation exposure limits as set forth in 47 C.F.R. 1.1310 (Apr. 1, 2020).

Abstract: Blood glucose states based at least on sensed brain activity data. Blood glucose states may be predicted states using prediction models, and may be real-time or future glucose states. One or more wearable sensors, optionally adapted for use in either single channel or dual channel sensing, can record brain activity signals and communicate brain activity signal data to a remote device.

Abstract: A measuring device includes a first light emitting section that emits first light; a light collecting section that has a first surface, a second surface that faces the first surface and that has a larger area than the first surface, and a wall surface that connects the first surface and the second surface and that allows the first light to pass therethrough; a light receiving section that is disposed on the first surface to receive the first light irradiated onto a living body from the second surface and returned from the living body; and a calculation section that receives an output from the light receiving section to calculate numerical information regarding the living body.

Abstract: A system which includes an apparatus for generating radio frequency scanning data which includes a transmitter for transmitting radio waves below the skin surface of a person and a two-dimensional array of receive antennas for receiving the radio waves, including a reflected portion of the transmitted radio waves that is reflected from a blood vessel of the person. The transmitter includes at least two different polarization orientations and the receive antennas have polarization orientations that correspond to the transmit antennas. The wave signal is compared to known standard waveforms, and similar waveforms are input into a machine learning algorithm to determine one or more health parameters of the person. The health parameters are recorded and may be later synchronized with a video recording. Alerts may warn health professionals when parameters are outside normal range. The health parameters may be used to direct a device.

Abstract: Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. Each microneedle of the microneedle array may include a microneedle body, an electrode material on the microneedle body, a biorecognition layer on the electrode material, a diffusion-limiting layer on the biorecognition layer, an interferent blocking agent, and/or an attachment enhancer between the biorecognition layer and the diffusion-limiting layer, where the interferent blocking agent and the attachment enhancer are configured to improve sensor sensitivity variability.

Abstract: A detection element of biological subcutaneous features and a wearable device thereof are provided. The element for detecting biological subcutaneous features has a substrate, a light-detecting semiconductor chip, a grid structure, and a cover. The light-detecting semiconductor chip is located on the substrate for detecting red light or near-infrared light signals. The grid structure including a plurality of opaque light-absorbing blocking walls is located on the light-detecting semiconductor chip for blocking side light and increasing the proportion of near-vertical incident light. The cover is located on the grid structure and serves as a protection lid. The wearable device for detecting biological subcutaneous features has more than one light source of red light or near-infrared light and a plurality of detection elements. The arrangement of the opaque light-absorbing blocking walls that are parallel to each other are substantially parallel to the light-emitting directions of the light source.

Abstract: A wearable device for monitoring physiological changes in a patient is provided. The device can include a housing adapted to being secured to a patient's body, the housing comprising a needle configured for fluid contact with a bodily fluid under a skin surface; a chamber having a cell layer and configured to monitor physiological changes in the bodily fluid and to generate one or more signals associated with the physiological changes; and a reader for detecting and/or decoding signals from the cell layer to monitor physiological changes in the patient. The device is capable of engaging in a two-way communication with a second device through transmission of one or more signals.

Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and—a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.

Abstract: A sample collection container configured to be removably mounted to a blood collection device includes a container body and a lid. The container body defines an interior configured to receive a sample provided from the blood collection device. The container body includes an upper portion having an open top and a lower portion having a closed bottom. The lid includes: a lid body; a flexible connection connected between the lid body and the upper portion of the container body that moves the lid between a closed position and an open position; a pierceable septum mounted to the lid body that seals the upper portion open top when the lid is in the closed position; and a latch. The latch extends from the lid body and engages a catch on the upper portion of the container body to secure the lid in the closed position.

Abstract: A kit of parts for obtaining a capillary blood sample includes a plurality of capillary blood collection devices of different sizes and a sizing tool for identifying which of the plurality of blood collection devices to use for a particular patient's finger. Each blood collection device of the plurality of blood collection devices can include a finger holder with a finger receiving portion designed for a unique ideal finger size and configured for use with fingers within a unique size range. Further, the plurality of devices are configured such that a majority of fingers for a population of patients are within one of the unique size ranges for the plurality of capillary blood collection devices.

Abstract: A fluid control device includes an inlet configured to be placed directly or indirectly in fluid communication with a bodily fluid source and an outlet configured to be placed in fluid communication with a fluid collection device. The fluid control device has a first state in which a negative pressure differential produced from an external source such as the fluid collection device is applied to the fluid control device to draw an initial volume of bodily fluid from the bodily fluid source, through the inlet, and into a sequestration portion of the fluid control device. The fluid control device has a second state in which (1) the sequestration portion sequesters the initial volume, and (2) the negative pressure differential draws a subsequent volume of bodily fluid, being substantially free of contaminants, from the bodily fluid source, through the fluid control device, and into the fluid collection device.

Abstract: A fluid control device includes an inlet configured to be placed directly or indirectly in fluid communication with a bodily fluid source and an outlet configured to be placed in fluid communication with a fluid collection device. The fluid control device has a first state in which a negative pressure differential produced from an external source such as the fluid collection device is applied to the fluid control device to draw an initial volume of bodily fluid from the bodily fluid source, through the inlet, and into a sequestration portion of the fluid control device. The fluid control device has a second state in which (1) the sequestration portion sequesters the initial volume, and (2) the negative pressure differential draws a subsequent volume of bodily fluid, being substantially free of contaminants, from the bodily fluid source, through the fluid control device, and into the fluid collection device.

Abstract: A fluid control device includes an inlet configured to be placed directly or indirectly in fluid communication with a bodily fluid source and an outlet configured to be placed in fluid communication with a fluid collection device. The fluid control device has a first state in which a negative pressure differential produced from an external source such as the fluid collection device is applied to the fluid control device to draw an initial volume of bodily fluid from the bodily fluid source, through the inlet, and into a sequestration portion of the fluid control device. The fluid control device has a second state in which (1) the sequestration portion sequesters the initial volume, and (2) the negative pressure differential draws a subsequent volume of bodily fluid, being substantially free of contaminants, from the bodily fluid source, through the fluid control device, and into the fluid collection device.

Abstract: A fluid control device includes an inlet configured to be placed directly or indirectly in fluid communication with a bodily fluid source and an outlet configured to be placed in fluid communication with a fluid collection device. The fluid control device has a first state in which a negative pressure differential produced from an external source such as the fluid collection device is applied to the fluid control device to draw an initial volume of bodily fluid from the bodily fluid source, through the inlet, and into a sequestration portion of the fluid control device. The fluid control device has a second state in which (1) the sequestration portion sequesters the initial volume, and (2) the negative pressure differential draws a subsequent volume of bodily fluid, being substantially free of contaminants, from the bodily fluid source, through the fluid control device, and into the fluid collection device.

Abstract: A fluid control device includes an inlet configured to be placed directly or indirectly in fluid communication with a bodily fluid source and an outlet configured to be placed in fluid communication with a fluid collection device. The fluid control device has a first state in which a negative pressure differential produced from an external source such as the fluid collection device is applied to the fluid control device to draw an initial volume of bodily fluid from the bodily fluid source, through the inlet, and into a sequestration portion of the fluid control device. The fluid control device has a second state in which (1) the sequestration portion sequesters the initial volume, and (2) the negative pressure differential draws a subsequent volume of bodily fluid, being substantially free of contaminants, from the bodily fluid source, through the fluid control device, and into the fluid collection device.

Abstract: A blood collection device may include a syringe with hemolysis protection. The syringe with hemolysis protection may be coupled to a catheter assembly and used for blood draw. The blood collection device may include the syringe, which may include a distal end, and a flow restrictor. The flow restrictor may include a distal end and a proximal end. The proximal end of the flow restrictor may be coupled to the distal end of the syringe, which may protect against hemolysis.

Abstract: Systems and methods for estimating emotional states, moods, affects of an individual and providing feedback to the individual or others are disclosed. Systems and methods that provide real time detection and monitoring of physical aspects of an individual and/or aspects of the individual's activity and means of estimating that person's emotional state or affect and change to those are also disclosed. Real time feedback to the individual about the person's emotional change, change or potential change is provided to the user, helping the user cope, adjust or appropriately act on their emotions.

Abstract: A monitoring system may include a processor and display system for displaying results from the monitoring. A user may be in a sterile field away from the processor and display system and selected input devices. A controller may be physically connected to the monitoring system from the sterile field to allow the user to control the monitoring system.

Abstract: Medical diagnostic devices and related methods of use are described in which one or multiple coils in a sensor, each coil connected with an RLC circuit and frequency counter, are held against a patient's head at predetermined cranial locations. Frequencies of the RLC circuit are measured and compared against those taken from known, control heads, to determine whether there is a medical problem and what type of problem. In some instances, too high of frequencies can reveal pooled blood in the head, a sign of hemorrhagic stroke, while too low of frequencies imply lack of blood supply, a sign of ischemic stroke. A head-mountable frame can assist a first responder in securing and guiding the coils and, along with fiducials, allow for automatic comparison of frequencies with the correct control data.

Abstract: The invention in one aspect relates to a conductive nanomaterial comprising acid-crystalized poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate) (PEDOT:PSS) nanoparticles (ncrys-PEDOTX) with intrinsic dispersibility.

Abstract: Methods and systems indicate where in the EP map the quality of the EP values is below a required level. Indications provide real-time visual aid to the physician, helping him or her to assess in which areas of the cardiac chamber additional EP signals need to be acquired in order to achieve the desired quality and sufficient spatial coverage.

Abstract: An evaluation method for evaluating a neurotransmission signal that is conducted through an axon bundle includes: performing a leveling that estimates a baseline of a signal waveform and subtracts an estimated baseline from the signal waveform; grouping a plurality of peaks that is contained in the signal waveform after the leveling into a plurality of groups each corresponding to one of the axons included in the axon bundle; calculating a similarity between a first signal waveform acquired by a first measurement electrode among a plurality of measurement electrodes and a second signal waveform acquired by a second measurement electrode, which is distinct from the first measurement electrode, after the grouping; and calculating a signal conduction time between the first measurement electrode and the second measurement electrode, based on a calculated similarity.

Abstract: An example method includes identifying data indicative of measurements of a physiological parameter of a subject over a time period. The data is divided into multiple segments including a first segment and a second segment. The method further includes determining a first label indicating whether the first segment is indicative of a condition; generating a first image that is indicative of the first segment; and determining, by inputting the first image into a trained machine learning (ML) model, that the first label is inaccurate. The method additionally includes determining a second label indicating whether the second segment is indicative of the condition; generating a second image that is indicative of the second segment; and determining, by inputting the second image into the trained ML model, that the second label is accurate. The method additionally includes outputting an indication of whether the subject has the condition based on the second label.

Abstract: An implantable medical device is configured to determine a first atrial arrhythmia score from ventricular events sensed by a sensing circuit of an implantable medical device and determine a second atrial arrhythmia score from an intraventricular signal comprising atrial mechanical event signals attendant to atrial systole and produced by a sensor of the implantable medical device. An atrial arrhythmia is detected based on the first atrial arrhythmia score and the second atrial arrhythmia score.

Abstract: A medical device system, such as an extra-cardiovascular implantable cardioverter defibrillator ICD, senses R-waves from a first cardiac electrical signal by a first sensing channel and stores a time segment of a second cardiac electrical signal in response to each sensed R-wave. The medical device system determines a morphology parameter correlated to signal noise from time segments of the second cardiac electrical signal, detects a noisy signal segment based on the signal morphology parameter; and withholds detection of a tachyarrhythmia episode in response to detecting a threshold number of noisy signal segments.

Abstract: The present disclosure relates to methods and devices for providing parameters that indicate a higher likelihood of a postoperative delirium occurring. According to an aspect of the present disclosure, the following steps are provided: detecting at least one EEG signal at the head of the patient; determining the average amplitude of the “direct current” EEG signal; checking whether an increase in the determined average amplitude when entering anesthetic-induced loss of consciousness is above a predefined amount, and in the event of this, providing a corresponding information in the form of a parameter that shows a higher likelihood of a postoperative delirium occurring.

Abstract: Some embodiments of the present disclosure are directed to methods, systems and probe devices for detecting EMG activity. In some embodiments, such methods, systems and devices are used in aiding the diagnosis of Obstruction Sleep Apnea. In some embodiments, a probe is provided and comprises an elongated member configured with a size and shape for placement adjacent at least one of the soft palate and pharyngeal wall of the patient after insertion of the probe into the patient, and includes at least one sensor configured to sense at least EMG activity of muscle layers of at least one of the soft palate and pharyngeal wall and output sensor signals corresponding thereto. The signals may be monitored for EMG activity, and based on such activity, in some embodiments, a determination of whether the sensor signals of the detected EMG activity correspond to spontaneous EMG activity and/or abnormal motor unit potentials.

Abstract: Systems and methods for analyzing whole-body balance comprise and perform the steps of: obtaining depth image data of a person's body during a predefined time period; tracking locations of a plurality of anatomical landmarks of the body based on the depth image data; estimating a mass center of the body based on a tracked location of each of one or more of the anatomical landmarks; and determining a stability of body, SoB, score based on a deviation of the estimated mass center over the predefined time period, wherein the SoB score is indicative of the whole-body balance.

Abstract: A method of demonstrating an effect of a cosmetic procedure on a subject, by using an analysing apparatus, wherein said method comprises the steps of providing lighting to said subject using a lighting setting, taking at least three photos of said subject after said cosmetic procedure has been performed on said subject, wherein for each of said at least three photos a different lighting setting is used, creating, by said analysing apparatus, an image have three dimensional based meta data, wherein said three dimensional based meta data is determined by calculating a plurality of normals of said subject using said at least three photos, thereby obtaining curvature information of said subject, implementing a skin model, wherein said skin model is based on a colour and a shining value of a skin of said subject and demonstrating, by said analysing apparatus, the effect of said cosmetic procedure by providing said image having said three dimensional based meta data in a virtual environment, and by differentiating

Abstract: A first aspect is provided by a pressure monitoring cushion 10 for supporting a seated or reclined person, the cushion comprises a pressure sensing means 22 for sensing a pressure exerted by a person on the cushion; a data logger 25 for monitoring and recording pressure measurements from the pressure sensing means 22; and a two-way communication means 26. In another aspect a system for monitoring pressure is provided. The system comprises a pressure monitoring cushion with a data logger 25 recording pressure measurements from pressure sensing means 22, and a two-way communication means 26 for selectively establishing a connection to an external device 42.

Abstract: Provided herein are methods of training a machine-learning model to detect a neurological condition. The methods include providing a neurological condition dataset comprising neurological condition text embeddings, the neurological condition text embeddings including large language model (LLM) text embeddings from subjects having the neurological condition; providing a control dataset comprising control text embeddings, the control text embeddings including LLM text embeddings from healthy subjects; and training the machine-learning model using the neurological condition dataset and the control dataset, forming a trained machine-learning model configured to detect a neurological condition. Also provided herein are methods of detecting a neurological condition using the trained machine-learning model.

Abstract: Methods and systems for obstructive sleep apnea diagnosis and prediction are disclosed. The methods and systems include: obtaining a white noise contaminated sensor signal for a patient; extracting a feature based on the white noise contaminated sensor signal; determining a matrix based on the feature; determining an intermittent forcing signal based on the matrix; determining an overcomplete representation of the intermittent forcing signal; and generating an obstructive sleep apnea indication based on the overcomplete representation and a threshold. Other aspects, embodiments, and features are also claimed and described.

Abstract: Embodiments are directed to an electronic device that includes a housing, a light emitter, a first detector positioned at a first separation distance from the light emitter, and a second detector positioned at a second separation distance from the light emitter. The electronic device can include a processor that is configured to cause the light emitter to emit light toward a user, receive a first measurement from the first detector based on a return of the emitted light from tissue of the user and receive a second measurement from the second detector based on a return of the emitted light from the tissue of the user. The processor can determine a decay constant of the emitted light using the first measurements and the second measurements, and determine a water content metric of the user using the determined decay constant.

Abstract: An annuler wearable electronic device includes a plurality of interconnected sensor pods. Each sensor pod includes one or more biosensors configured to collect biometric signal data of a user and each sensor pod is coupled to at least one adjacent sensor pod via a rigid, non-elastic coupling arm such that a circumference of the wearable electronic device is variable.

Abstract: An applicator, according to the present invention, for inserting, into the skin of a user, a sensor for measuring biological information comprises: an applicator body, which can come in contact with the skin of a user; an insertion unit provided at the applicator body in order to move, from a first position at which a sensor unit is spaced from the skin of the user to a second position at which the sensor unit is inserted into the skin of the user, the sensor unit, including the sensor, a sensor unit housing in which the sensor is mounted, an adhesive layer provided on the sensor unit housing, and a protective sheet for covering the adhesive layer; a removing unit provided at the applicator body so as to separate the protective sheet from the adhesive layer before the sensor unit reaches the second position; and an operating member provided at the applicator body so as to be operated by the user, and thus enable the removing unit to be operated.

Abstract: There is provided a method to estimate a period characteristic, such as period length or a period location, of a physiological rhythm, such as a cardiac rhythm or a spontaneous breathing rhythm. The method comprises receiving the signal representing the physiological rhythm, estimating a first group of period characteristic estimations based on the signal, generating a prior probability for the period characteristic based on at least a subset of the first group of period characteristic estimations, and estimating a second group of period characteristic estimations based on the first group and the prior probability. By using this method, the accuracy of the signal is improved, especially when the signal is obtained from an accelerometer arranged on the chest of the subject.

Abstract: The wireless heart telemetry device and accompanied patient monitoring system provides continuous patient monitoring in a comfortable and streamlined design for healthcare settings by providing electrocardiogram (ECG) physiological data in a wireless skin patch device. The wireless heart telemetry device integrates into a full patient monitoring system to provide additional vital physiological patient data in wireless system. This additional physiological data includes pleth, blood oxygen saturation (SPO2), blood pressure, heart rate, respiration rate, temperature, and glucose. The pulse oximeter portion of the system includes mechanical designs such as a finger clip, ring, and bracelet design for enhanced usage, accuracy, and comfort. Another example embodiment of the pulse oximeter portion of the system includes fall detection, bed alarm, and location monitoring services. An additional example embodiment includes a melanin bias reducing pulse oximeter.

Abstract: In an embodiment, a data processing method comprises obtaining one or more photoplethysmography (PPG) signals from one or more PPG sensors of a monitoring apparatus, the PPG signals being generated based upon optically detecting pulsed variations in blood flow; obtaining a motion sensor signal from a motion sensor in the monitoring apparatus; identifying, based upon the motion sensor signal, one or more periods of motion (e.g., low motion) of the monitoring apparatus; and selectively obtaining and storing segments of the PPG signals based on a temporal relationship between the segments of the PPG signals and the identified periods of motion.

Abstract: Seizure onset can be forecast in subjects from subcutaneous electroencephalography (EEG) data input to a trained machine learning algorithm. A multi-stage training process is used to train the machine learning algorithm. A first stage of the training process is implemented on scalp-recorded EEG data. A second stage of the training process may be implemented on subcutaneously recorded EEG data.

Abstract: A biometric information display device includes circuitry, and a memory storing computer-executable instructions that cause the circuitry to display at least one biological signal waveform including a biological signal measured, and display a graphic representation representing a noise level included in the biological signal waveform at a location corresponding to a peak of the biological signal waveform.

Abstract: Systems and methods are provided for a patient table. The patient table may include a bed coupled to a base via a midsection and a docking bar coupled to the base. The docking bar may be movable between a first position, where a first longitudinal axis of the docking bar is parallel to a second longitudinal axis of the base, and a second position, where the first longitudinal axis is perpendicular to the second longitudinal axis. The docking bar may include a releasable bottom surface configured to be brought into contact with a base support of a patient lift.

Abstract: A biometric apparatus including an irradiation device configured to deliver radiation to a subject, a radiation detector configured to perform radiation imaging on a test site of the subject, and a magnetic detector configured to detect biomagnetism of the subject, the magnetic detector being placed between the radiation detector and the irradiation device.

Abstract: Radiological imaging equipment includes a signal detector configured to convert a scintillation signal output from a scintillation crystal into an electrical signal, and a signal processor configured to amplify an output signal of the signal detector and to output a time in which an amplified signal is maintained above a threshold, wherein the signal processor includes a first clipping circuit and a second clipping circuit configured to sequentially clip the amplified signal according to the threshold.

Abstract: Provided is an X-ray imaging apparatus that enables an operator to freely manually move an X-ray source along a rail installed on a ceiling or a floor, and can capture a fluoroscopic image. An X-ray control unit continuously emitting X-rays from an X-ray source and permits fluoroscopy only in a case in which one or more predetermined conditions, including a condition in which the X-ray source is stopped at a predetermined position on a rail corresponding to a position at which an X-ray detector is held, are satisfied. Specifically, the X-ray control unit enables an operation of a fluoroscopy switch, and continuously supplies a tube current and a tube voltage to the X-ray tube in a case in which the operator operates the fluoroscopy switch.

Abstract: A method for processing breast tissue image data includes processing the image data to generate a set of image slices collectively depicting the patient's breast; for each image slice, applying one or more filters associated with a plurality of multi-level feature modules, each configured to represent and recognize an assigned characteristic or feature of a high-dimensional object; generating at each multi-level feature module a feature map depicting regions of the image slice having the assigned feature; combining the feature maps generated from the plurality of multi-level feature modules into a combined image object map indicating a probability that the high-dimensional object is present at a particular location of the image slice; and creating a 2D synthesized image identifying one or more high-dimensional objects based at least in part on object maps generated for a plurality of image slices.